• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中左旋多巴诱导的运动障碍的病理生理学:当前模型存在的问题。

Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: problems with the current model.

作者信息

Obeso J A, Rodriguez-Oroz M C, Rodriguez M, DeLong M R, Olanow C W

机构信息

Department of Neurology and Neurosurgery, Clínica Universitaria and Medical School, University of Navarra, Pamplona, Spain.

出版信息

Ann Neurol. 2000 Apr;47(4 Suppl 1):S22-32; discussion S32-4.

PMID:10762129
Abstract

The anatomical and physiological basis of levodopa-induced dyskinesias (LIDs) in patients with Parkinson's disease (PD) is reviewed in the light of the current model for the organization of the basal ganglia. This model, which was developed in the late 1980s, works relatively well in explaining the motor features of PD but, for example, it does not account for why tremor, rigidity, bradykinesia, gait dysfunction and postural instability present to differing degrees in different patients, and may respond differently to levodopa treatment or surgical procedures. Recent information suggests that LIDs develop as a consequence of pulsatile stimulation of dopamine receptors, with consequent dysregulation of genes and proteins in downstream neurons resulting in changes in neuronal firing patterns. A modified model of the basal ganglia in PD patients with LID is proposed, which incorporates more recent clinical and experimental data.

摘要

根据当前基底神经节组织模型,对帕金森病(PD)患者左旋多巴诱发异动症(LIDs)的解剖学和生理学基础进行了综述。该模型于20世纪80年代末提出,在解释PD的运动特征方面效果相对较好,但例如,它无法解释为什么震颤、强直、运动迟缓、步态功能障碍和姿势不稳在不同患者中表现程度不同,并且对左旋多巴治疗或手术程序的反应可能不同。最新信息表明,LIDs是多巴胺受体脉冲刺激的结果,下游神经元中的基因和蛋白质随之失调,导致神经元放电模式改变。本文提出了一个适用于LID的PD患者的基底神经节修正模型,该模型纳入了更多最新的临床和实验数据。

相似文献

1
Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: problems with the current model.帕金森病中左旋多巴诱导的运动障碍的病理生理学:当前模型存在的问题。
Ann Neurol. 2000 Apr;47(4 Suppl 1):S22-32; discussion S32-4.
2
The neural mechanisms underlying levodopa-induced dyskinesia in Parkinson's disease.帕金森病中左旋多巴诱发异动症的神经机制。
Ann Neurol. 2000 Apr;47(4 Suppl 1):S105-12; discussion S112-4.
3
Pathophysiology of motor fluctuations in Parkinson's disease.帕金森病运动波动的病理生理学
Mov Disord. 2005;20 Suppl 11:S17-22. doi: 10.1002/mds.20459.
4
Dyskinesias and the subthalamic nucleus.运动障碍与底丘脑核
Ann Neurol. 2000 Apr;47(4 Suppl 1):S189-92.
5
Clinical physiology of dopa dyskinesia.多巴异动症的临床生理学
Ann Neurol. 2000 Apr;47(4 Suppl 1):S147-50; discussion S150-3.
6
Pathophysiology of levodopa-induced dyskinesia: potential for new therapies.左旋多巴诱导的运动障碍的病理生理学:新疗法的潜力
Nat Rev Neurosci. 2001 Aug;2(8):577-88. doi: 10.1038/35086062.
7
Physiologic basis of dyskinesia.运动障碍的生理基础。
Ann Neurol. 2000 Apr;47(4 Suppl 1):S35-40; discussion S40-1.
8
Surgery for levodopa-induced dyskinesias.
Ann Neurol. 2000 Apr;47(4 Suppl 1):S193-9; discussion S199-202.
9
Levodopa-induced dyskinesias in Parkinson's disease: etiology, impact on quality of life, and treatments.帕金森病中左旋多巴诱发的异动症:病因、对生活质量的影响及治疗方法
Eur Neurol. 2008;60(2):57-66. doi: 10.1159/000131893. Epub 2008 May 15.
10
Preventing levodopa-induced dyskinesias.预防左旋多巴诱发的运动障碍。
Ann Neurol. 2000 Apr;47(4 Suppl 1):S167-76; discussion S176-8.

引用本文的文献

1
Deep brain stimulation-induced two manners to eliminate bursting for Parkinson's diseases: synaptic current and bifurcation mechanisms.深部脑刺激诱导的消除帕金森病爆发的两种方式:突触电流和分岔机制。
Cogn Neurodyn. 2025 Dec;19(1):78. doi: 10.1007/s11571-025-10267-5. Epub 2025 May 19.
2
Decoupling of motor cortex to movement in Parkinson's dyskinesia rescued by sub-anaesthetic ketamine.亚麻醉剂量氯胺酮可挽救帕金森病异动症中运动皮层与运动的解耦联。
Brain. 2025 Jun 3;148(6):2135-2150. doi: 10.1093/brain/awae386.
3
Pharmacotherapy of motor symptoms in early and mid-stage Parkinson's disease: guideline "Parkinson's disease" of the German Society of Neurology.
早期和中期帕金森病运动症状的药物治疗:德国神经病学学会指南“帕金森病”。
J Neurol. 2024 Nov;271(11):7071-7101. doi: 10.1007/s00415-024-12632-6. Epub 2024 Aug 29.
4
Role of the globus pallidus in motor and non-motor symptoms of Parkinson's disease.苍白球在帕金森病运动和非运动症状中的作用。
Neural Regen Res. 2025 Jun 1;20(6):1628-1643. doi: 10.4103/NRR.NRR-D-23-01660. Epub 2024 Jun 3.
5
Axon terminal hypertrophy of striatal projection neurons with levodopa-induced dyskinesia priming.左旋多巴诱发异动症启动时纹状体投射神经元的轴突终末肥大
Front Neurosci. 2023 Jun 7;17:1169336. doi: 10.3389/fnins.2023.1169336. eCollection 2023.
6
The role of neurotransmitter systems in mediating deep brain stimulation effects in Parkinson's disease.神经递质系统在介导帕金森病深部脑刺激效应中的作用。
Front Neurosci. 2022 Oct 5;16:998932. doi: 10.3389/fnins.2022.998932. eCollection 2022.
7
Neurobiological and Pharmacological Perspectives of D3 Receptors in Parkinson's Disease.帕金森病中 D3 受体的神经生物学和药理学观点。
Biomolecules. 2022 Feb 1;12(2):243. doi: 10.3390/biom12020243.
8
Histological Correlates of Neuroanatomical Changes in a Rat Model of Levodopa-Induced Dyskinesia Based on Voxel-Based Morphometry.基于体素形态学的左旋多巴诱导的异动症大鼠模型中神经解剖学变化的组织学关联
Front Aging Neurosci. 2021 Oct 28;13:759934. doi: 10.3389/fnagi.2021.759934. eCollection 2021.
9
Low-frequency transcranial stimulation of pre-supplementary motor area alleviates levodopa-induced dyskinesia in Parkinson's disease: a randomized cross-over trial.低频经颅刺激辅助运动前区可缓解帕金森病患者的左旋多巴诱导性异动症:一项随机交叉试验
Brain Commun. 2020 Sep 18;2(2):fcaa147. doi: 10.1093/braincomms/fcaa147. eCollection 2020.
10
Acute levodopa dosing around-the-clock ameliorates REM sleep without atonia in hemiparkinsonian rats.在偏侧帕金森病大鼠中,全天候急性给予左旋多巴可改善快速眼动睡眠无张力状态。
NPJ Parkinsons Dis. 2019 Nov 29;5:27. doi: 10.1038/s41531-019-0096-2. eCollection 2019.